# Cherry Hill Mortgage Investment Corp: overview

CHMI · NYSE · CIK 1571776 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/chmi.md) · [Financials](/companies/chmi/financials.md) · [Filings](/companies/chmi/filings.md) · [Insiders](/companies/chmi/insiders.md)

Latest reported revenue: [$6.6m](/filings/0001140361-26-041174.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 29, 2026 (XBRL us-gaap:RevenuesNetOfInterestExpense, accession 0001140361-26-041174).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [18.7 d](/filings/0001140361-26-008094.md) | [(3.1)](/filings/0001140361-26-019561.md) | [6.0](/filings/0001140361-26-032050.md) | [8.6](/filings/0001140361-26-041174.md) | [11.8 d](/filings/0001140361-26-008094.md) | [4.6](/filings/0001140361-26-019561.md) | [7.9](/filings/0001140361-26-032050.md) | [6.6](/filings/0001140361-26-041174.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [63.1% d](/filings/0001140361-26-008094.md) | [229.2%](/filings/0001140361-26-041174.md) | [25.9%](/filings/0001140361-26-041174.md) | [52.7%](/filings/0001140361-26-041174.md) | [66.8% d](/filings/0001140361-26-008094.md) | [9.2%](/filings/0001140361-26-041174.md) | [48.2%](/filings/0001140361-26-041174.md) | [(22.5%)](/filings/0001140361-26-041174.md) |
| Diluted EPS | $ per share | not reported | [(0.29)](/filings/0001140361-26-019561.md) | [(0.03)](/filings/0001140361-26-032050.md) | [0.05](/filings/0001140361-26-041174.md) | not reported | [(0.05)](/filings/0001140361-26-019561.md) | [0.04](/filings/0001140361-26-032050.md) | [(0.11)](/filings/0001140361-26-041174.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenuesNetOfInterestExpense. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenuesNetOfInterestExpense. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenuesNetOfInterestExpense. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:RevenuesNetOfInterestExpense. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [28.1](/filings/0001140361-24-011952.md) | [40.2](/filings/0001140361-25-007454.md) | [(21.2)](/filings/0001140361-26-008094.md) | [34.6](/filings/0001140361-26-008094.md) | [23.3](/filings/0001140361-26-008094.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [44.5%](/filings/0001140361-24-011952.md) | [55.2%](/filings/0001140361-25-007454.md) | [167.2%](/filings/0001140361-26-008094.md) | [35.3%](/filings/0001140361-26-008094.md) | [29.8%](/filings/0001140361-26-008094.md) |
| Diluted EPS | $ per share | [0.14](/filings/0001140361-24-011952.md) | [0.60](/filings/0001140361-25-007454.md) | [(1.70)](/filings/0001140361-26-008094.md) | [0.07](/filings/0001140361-26-008094.md) | [(0.09)](/filings/0001140361-26-008094.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenuesNetOfInterestExpense.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenuesNetOfInterestExpense.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenuesNetOfInterestExpense.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:RevenuesNetOfInterestExpense.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/chmi/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $3.5m | 1,508,070 |  | Reduced −60,729 |
| [Summit Financial, LLC](/funds/1765536.md) | 2026-06-30 | $2.5m | 1,020,091 |  | Reduced −4,762 |
| [TPG GP A, LLC](/funds/1903793.md) | 2026-06-30 | $1.7m | 734,800 |  | Added +178,195 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $1.3m | 562,984 |  | Reduced −46,200 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.1m | 475,688 |  | Added +31,452 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $959.3k | 413,427 |  | Reduced −96,611 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $614.7k | 264,978 |  | Reduced −8,914 |
| [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $521.6k | 224,826 |  | Added +1,485 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $397.6k | 164,291 |  | Unchanged |
| [Corient Private Wealth LP](/funds/1948780.md) | 2026-06-30 | $396.5k | 170,916 |  | Added +1,380 |

## Recent filings

[All 429 filings](/companies/chmi/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:31 ET | [8-K](/filings/0001140361-26-041175.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-041175 |
| 2026-10-29 | 16:31 ET | [10-Q](/filings/0001140361-26-041174.md) | Quarterly report, period 2026-09-30 | 0001140361-26-041174 |
| 2026-08-10 | 16:59 ET | [10-Q](/filings/0001140361-26-032050.md) | Quarterly report, period 2026-06-30 | 0001140361-26-032050 |
| 2026-08-10 | 07:00 ET | [8-K](/filings/0001140361-26-031932.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-031932 |
| 2026-08-10 | 06:46 ET | [8-K](/filings/0001140361-26-031930.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-031930 |
| 2026-06-12 | 11:40 ET | [8-K](/filings/0001140361-26-025024.md) | 5.07 Shareholder vote results | 0001140361-26-025024 |
| 2026-05-07 | 16:41 ET | [8-K](/filings/0001140361-26-019570.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-019570 |
| 2026-05-07 | 16:38 ET | [10-Q](/filings/0001140361-26-019561.md) | Quarterly report, period 2026-03-31 | 0001140361-26-019561 |
| 2026-04-21 | 16:05 ET | [DEF 14A](/filings/0001140361-26-015895.md) | Proxy statement, period 2026-06-11 | 0001140361-26-015895 |
| 2026-04-10 | 16:01 ET | [8-K](/filings/0001140361-26-014230.md) | 5.02 Departure or appointment of officers or directors | 0001140361-26-014230 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001140361-26-008094.md), filed Mar 5, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/292edfcf-70d9-4a68-8c41-26ffde2924e6)

## About the filer

- CIK: 1571776
- Tickers: CHMI, CHMI-PB, CHMI-PA
- Exchange: NYSE
- SIC code: 6798 Real Estate Investment Trusts
- State of incorporation: MD
- Filer category: Accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 11:28 ET. No prices; not investment advice.